Treatment of poor prognosis metastatic teratoma

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN14535482

Enrollment

154

Registered

2001-02-28

Start date

1991-02-01

Completion date

Unknown

Last updated

2019-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metastatic teratoma Cancer Metastatic teratoma

Interventions

Arm 1 - Without granulocyte colony stimulating factor (G-CSF), BEP/EP. Arm 2 - Without G-CSF, BOP/VIP-B. Arm 3 - With G-CSF, BEP/EP. Arm 4 - With G-CSF,

Eligibility

Inclusion criteria

Inclusion criteria: Histologically proven non-seminomatous germ cell tumour

Exclusion criteria

Exclusion criteria: Previous radiotherapy or chemotherapy

Design outcomes

Primary

Measure	Time frame
Progression-free survival	—

Secondary

Measure	Time frame
Response rate, overall survival	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026